Compare ZLAB & AI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZLAB | AI |
|---|---|---|
| Founded | 2013 | 2009 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.1B |
| IPO Year | 2017 | 2020 |
| Metric | ZLAB | AI |
|---|---|---|
| Price | $18.67 | $16.09 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 16 |
| Target Price | ★ $57.22 | $24.29 |
| AVG Volume (30 Days) | 810.7K | ★ 6.6M |
| Earning Date | 11-06-2025 | 12-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $441,629,000.00 | $352,913,000.00 |
| Revenue This Year | $30.20 | N/A |
| Revenue Next Year | $34.71 | $11.61 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 24.14 | 1.84 |
| 52 Week Low | $18.61 | $12.59 |
| 52 Week High | $44.34 | $45.08 |
| Indicator | ZLAB | AI |
|---|---|---|
| Relative Strength Index (RSI) | 21.76 | 57.61 |
| Support Level | $19.40 | $14.80 |
| Resistance Level | $20.22 | $15.87 |
| Average True Range (ATR) | 0.53 | 0.75 |
| MACD | 0.20 | 0.36 |
| Stochastic Oscillator | 5.02 | 96.38 |
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Platform, which is an end-to-end application development and runtime environment for designing, developing, and deploying AI applications: C3 AI Applications, which is a portfolio of pre-built, extensible, industry-specific, and application-specific Enterprise AI applications: and C3 Generative AI, which combines the utility of large language models. Geographically the company derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and the Rest of the World.